Sign in

NCT06397404Completed

VExUS in Patients With Acute Heart Failure

Congestion Assessment Using Venous Excess Ultrasound Score (VExUS) in Patients With Acute Heart Failure

Source: ClinicalTrials.gov · Last updated 20 May 2024

Brief summary (registry, in English)

The importance of assessing venous congestion in heart failure patients is widely acknowledged, but its study is hampered by the lack of a practical evaluation tool. Venous excess ultrasound score (VExUS) is a promising noninvasive ultrasound-guided modality that can detect and objectify clinically significant organ congestion. VExUS congestion grading score was still not formally validated in patients with AHF, as there is limited data on its clinical application in this group of patients.

Status (registry)
Completed
Study type
Observational
Enrollment
100 (actual)
First submitted
6 Apr 2024
Start date
18 May 2023
Primary completion date
25 Nov 2023
Lead sponsor
I.M. Sechenov First Moscow State Medical University
NCT number
NCT06397404

What you commit to

  • Study type: Observational
  • Participants enrolled: 100
  • From 18 May 2023 to the primary completion date, 25 Nov 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Chronic renal replacement therapy or glomerular filtration rate \< 15 ml/min/1.73m 2 (chronic kidney disease Epidemiology Collaboration (CKD)-EPI)
  • Cirrhosis with portal hypertension
  • Acute myocardial infarction according to The Fourth Universal Definition of Myocardial infarction
  • Active cancer
  • Neurological or mental disease during exacerbation

Other

  • Pulmonary embolism
  • Sepsis (according to The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3))
  • Endotracheal intubation at the time of admission
  • Pregnancy or breastfeeding
  • Aortic dissection
  • Refusal to sign an informed consent form, inadequate acoustic window

Who the study is looking for

  • Acute decompensation of heart failure (diagnosis was based on the European Society of Cardiology (ESC) heart failure guidelines, with patients presenting with dyspnoea at rest or with minimal exertion and signs and symptoms of congestion (rales on chest auscultation, peripheral oedema, swelling of the cervical veins, hepatomegaly, ascites, hepatojugular reflux) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) \> 1000 pg/ml

Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
City clinical hospital named after S. S. Yudin, Moscow City Health Department, Moscow, Russian Federation
Coordinator of this site? Confirm its status
MoscowRussiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.